Guerrero Ramiro's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Sep 1, 2026
- Accession no.
- 0001878313-26-000082
- Filed
- Sep 1, 2026, 4:16 PM ET
- Trade date
- Aug 26-28, 2026
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $184.1K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guerrero RamiroCIK 0001913253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | PPurchaseAcquired | +8,931 | $1.39 | +$12,414.09 | 610,842 | Direct | |
| Aug 27, 2026 | Common Stock | PPurchaseAcquired | +78,239 | $1.39 | +$108,752.21 | 689,081 | Direct | |
| Aug 28, 2026 | Common Stock | PPurchaseAcquired | +46,620 | $1.35 | +$62,937 | 735,701 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.